{
  "docId": "019de076-57a4-77f9-94ab-9b0feede6704",
  "docSlug": "a14e4b0042ed971c9f1fd15d53e19956",
  "documentTitle": "MaxCyte | Results Presentation Deck | 25 slides",
  "authorId": "maxcyte",
  "authorName": "MaxCyte",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 25,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "valuation_reveal",
  "function": "size_opportunity",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": "The chart shows a cumulative growth curve of partner logos over time (2017-2023).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-57a4-77f9-94ab-9b0feede6704/9",
  "deckHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704",
  "deckJsonHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704.json",
  "deckAnchorHref": "/decks/019de076-57a4-77f9-94ab-9b0feede6704#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.68,
        "w": 0.44,
        "x": 0.51,
        "y": 0.14
      },
      "kind": "chart",
      "text": "Cumulative Potential Pre-CML Milestones",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d063c928-6d31-48ba-97ba-364102c4f9ea",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.3,
        "x": 0.14,
        "y": 0.33
      },
      "kind": "list",
      "text": "Potential value of pre-commercial (clinical development) milestones from SPLs: ~$2B",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "47ed29db-42d9-48c6-896a-50ec583c0777",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.3,
        "x": 0.14,
        "y": 0.73
      },
      "kind": "list",
      "text": "Milestone revenue is MaxCyte's highest growth revenue stream",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "632dd764-36b1-4b8c-8d34-f702c32fd9e2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.35,
        "x": 0.14,
        "y": 0.58
      },
      "kind": "list",
      "text": "Recurring revenues from lease of instruments and sales of single-use disposables that grow with program success",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a5497440-987f-4ba9-9b35-6ee9694d8312",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.3,
        "x": 0.14,
        "y": 0.46
      },
      "kind": "list",
      "text": "Sales-based payments upon partner's product commercialization",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bb3dd9f9-1f8e-4287-a8f0-8641ce1129e6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.35,
        "x": 0.14,
        "y": 0.18
      },
      "kind": "paragraph",
      "text": "Licensing deals include significant development milestones and high-value participation in future commercial success of partners",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bc5614da-c8dd-47db-9b86-bce7bc37712d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.08,
        "y": 0.83
      },
      "kind": "source-note",
      "text": "**Casebia/CRISPR's SPL partnership (signed in 2017) included the rights to use MaxCyte's technology in the development of exa-cel (formerly known as CTX001). As announced in the press release on September 28th, 2022, Vertex has signed an SPL agreement with MaxCyte - Vertex has obtained the clinical and commercial rights to use MaxCyte's technology for the development of exa-cel (formerly known as CTX001).",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4500f427-f490-4266-b398-86d010a6fe63",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "Value Creation from SPLs",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "042c5780-3474-4588-99ae-f286868fcc0f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Waterfall chart",
      "slug": "waterfall-chart",
      "agent": null,
      "layer": "slide",
      "matchId": "219e062b-105b-469b-8661-72b9b04e30aa",
      "evidence": "chart/line: Cumulative Potential Pre-CML Milestones",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "19745f31-8a89-4237-8a14-1a2453158cb8",
      "evidence": "Chronological progression of partner logos from 2017 to 2023",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 12,
      "from": 9,
      "beatId": "df1ea0f5-4795-4962-88b6-1dc947bcf2f8",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Market Size",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "Slides 9-12 discuss revenue potential and partnerships",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 12,
      "from": 9,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "95f03eb0-9033-4b1b-a24a-ab6d09f47a8d",
      "evidence": "Slides 9-12 discuss revenue upside and partnerships",
      "position": 1,
      "objective": "Showcase revenue potential",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.7,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}